Miravo Healthcare™ Announces Fourth Quarter 2021 Results Release Date and Conference Call Details

Rhea-AI Summary

Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) will announce its fourth quarter 2021 financial results on March 28, 2022, before market opening. Following the announcement, a conference call led by President & CEO Jesse Ledger is scheduled for the same day at 11:00 a.m. ET. Investors can join by dialing (289) 536-4777 or 1 (888) 550-2239. An audio webcast will be available online for those who wish to access the event remotely.

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its fourth quarter 2021 financial results before markets open on Monday, March 28, 2022.

The Company will subsequently hold a conference call the same day, Monday, March 28, 2022 at 11:00 a.m. ET, hosted by Jesse Ledger, Miravo’s President & Chief Executive Officer and other senior management. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE: Monday, March 28, 2022

TIME: 11:00 a.m. ET

DIAL-IN NUMBERS: (289) 536-4777 or 1 (888) 550-2239

The audio webcast and webcast replay can be accessed at: https://onlinexperiences.com/Launch/QReg/ShowUUID=4A4D2771-F21A-47AB-82F9-727FEDA78FB2

About Miravo Healthcare

Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220314005258/en/

Investor Relations

Stefan Eftychiou

905 326 1888 ext 60

stefan@bristolir.com

Source: Nuvo Pharmaceuticals Inc.

FAQ

When will Nuvo Pharmaceuticals release its Q4 2021 financial results?

Nuvo Pharmaceuticals will release its Q4 2021 financial results on March 28, 2022.

What time is the conference call for Nuvo Pharmaceuticals' Q4 2021 financial results?

The conference call is scheduled for 11:00 a.m. ET on March 28, 2022.

How can I join the Nuvo Pharmaceuticals conference call?

You can join the conference call by dialing (289) 536-4777 or 1 (888) 550-2239.

Is there a webcast available for Nuvo Pharmaceuticals' conference call?

Yes, an audio webcast will be available for the conference call.